BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND BCL6, BCL5, 603, 604, ENSG00000113916, ZBTB27, P41182, LAZ3, BCL6A, ZNF51 AND Prognosis
18 results:

  • 1. Nomogram model for predicting early recurrence for resectable pancreatic cancer: A multicenter study.
    Man Q; Pang H; Liang Y; Chang S; Wang J; Gao S
    Medicine (Baltimore); 2024 Mar; 103(10):e37440. PubMed ID: 38457597
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Increasing Systemic Immune-inflammation Index During Treatment in Patients With Advanced pancreatic cancer is Associated With Poor Survival: A Retrospective, Multicenter, Cohort Study.
    van 't Land FR; Aziz MH; Michiels N; Mieog JSD; Bonsing BA; Luelmo SAC; Homs MYV; Groot Koerkamp B; Papageorgiou G; van Eijck CHJ
    Ann Surg; 2023 Dec; 278(6):1018-1023. PubMed ID: 37010512
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Postoperative complications and short-term prognosis of laparoscopic pancreaticoduodenectomy vs. open pancreaticoduodenectomy for treating pancreatic ductal adenocarcinoma: a retrospective cohort study.
    Zhang B; Xu Z; Gu W; Zhou J; Tang N; Zhang S; Chen C; Zhang Z
    World J Surg Oncol; 2023 Jan; 21(1):26. PubMed ID: 36710324
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Long-Term Effect of pancreaticoduodenectomy Combined with Revascularization for Resectable pancreatic Carcinoma in Elderly Patients.
    Yang J; Xu Z; Zhang J; Zheng Y; Gu J; Zhou Q; Wang X; Guo S; Zhang H; Chen S; Wang H
    Med Sci Monit; 2022 Nov; 28():e938443. PubMed ID: 36404606
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes.
    Meagher NS; Gorringe KL; Wakefield M; Bolithon A; Pang CNI; Chiu DS; Anglesio MS; Mallitt KA; Doherty JA; Harris HR; Schildkraut JM; Berchuck A; Cushing-Haugen KL; Chezar K; Chou A; Tan A; Alsop J; Barlow E; Beckmann MW; Boros J; Bowtell DDL; ; Brand AH; Brenton JD; Campbell I; Cheasley D; Cohen J; Cybulski C; Elishaev E; Erber R; Farrell R; Fischer A; Fu Z; Gilks B; Gill AJ; ; Gourley C; Grube M; Harnett PR; Hartmann A; Hettiaratchi A; Høgdall CK; Huzarski T; Jakubowska A; Jimenez-Linan M; Kennedy CJ; Kim BG; Kim JW; Kim JH; Klett K; Koziak JM; Lai T; Laslavic A; Lester J; Leung Y; Li N; Liauw W; Lim BWX; Linder A; Lubiński J; Mahale S; Mateoiu C; McInerny S; Menkiszak J; Minoo P; Mittelstadt S; Morris D; Orsulic S; Park SY; Pearce CL; Pearson JV; Pike MC; Quinn CM; Mohan GR; Rao J; Riggan MJ; Ruebner M; Salfinger S; Scott CL; Shah M; Steed H; Stewart CJR; Subramanian D; Sung S; Tang K; Timpson P; Ward RL; Wiedenhoefer R; Thorne H; ; Cohen PA; Crowe P; Fasching PA; Gronwald J; Hawkins NJ; Høgdall E; Huntsman DG; James PA; Karlan BY; Kelemen LE; Kommoss S; Konecny GE; Modugno F; Park SK; Staebler A; Sundfeldt K; Wu AH; Talhouk A; Pharoah PDP; Anderson L; DeFazio A; Köbel M; Friedlander ML; Ramus SJ
    Clin Cancer Res; 2022 Dec; 28(24):5383-5395. PubMed ID: 36222710
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Meta-analysis on prognostic value of KRAS mutation in resected mass-forming cholangiocarcinoma.
    Procopio F; Branciforte B; Nappo G; Di Tommaso L; Lleo A; Torzilli G
    Eur J Surg Oncol; 2022 Jul; 48(7):1455-1463. PubMed ID: 35317947
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Impact of the SARS-CoV-2 pandemic on pancreatic cancer: diagnosis and short-term survival.
    Tejedor-Tejada J; Gómez-Díez C; Robles Gaitero S; Villar Caamaño A; Hermida Pérez B; Olmos JM; Álvarez Álvarez A; Tojo González R
    Rev Esp Enferm Dig; 2022 Aug; 114(8):509-510. PubMed ID: 35297265
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Prognostic value of the preoperative fibrinogen-to-albumin ratio in pancreatic ductal adenocarcinoma patients undergoing R0 resection.
    Zhang LP; Ren H; Du YX; Wang CF
    World J Gastroenterol; 2020 Dec; 26(46):7382-7404. PubMed ID: 33362391
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Grading Solid Pseudopapillary Tumors of the Pancreas: the Fudan Prognostic Index.
    Yang F; Wu W; Wang X; Zhang Q; Bao Y; Zhou Z; Jin C; Ji Y; Windsor JA; Lou W; Fu D
    Ann Surg Oncol; 2021 Jan; 28(1):550-559. PubMed ID: 32424583
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Combining Aspartate Aminotransferase-to-Platelet Ratio Index with Future Liver Remnant to Assess Preoperative Hepatic Functional Reserve in Patients with Hepatocellular Carcinoma.
    Mai RY; Zeng J; Lu HZ; Liang R; Lin Y; Piao XM; Gao X; Wu GB; Wu FX; Ma L; Xiang BD; Li LQ; Ye JZ
    J Gastrointest Surg; 2021 Mar; 25(3):688-697. PubMed ID: 32274631
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Optimized modification of the eighth edition of AJCC TNM staging system for resected pancreatic ductal adenocarcinoma.
    Pu N; Yin L; Habib JR; Gao S; Hu H; Zhu Y; Wu Y; Yu J; Lou W
    Future Oncol; 2019 Oct; 15(30):3457-3465. PubMed ID: 31460788
    [No Abstract]    [Full Text] [Related]  

  • 12. Nodal downstaging as a treatment goal for node-positive pancreatic cancer.
    Portuondo JI; Massarweh NN; Zhang Q; Chai CY; Tran Cao HS
    Surgery; 2019 Jun; 165(6):1144-1150. PubMed ID: 30745009
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial.
    Zhu AX; Kang YK; Yen CJ; Finn RS; Galle PR; Llovet JM; Assenat E; Brandi G; Pracht M; Lim HY; Rau KM; Motomura K; Ohno I; Merle P; Daniele B; Shin DB; Gerken G; Borg C; Hiriart JB; Okusaka T; Morimoto M; Hsu Y; Abada PB; Kudo M;
    Lancet Oncol; 2019 Feb; 20(2):282-296. PubMed ID: 30665869
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. BRCA1 missense polymorphisms are associated with poor prognosis of pancreatic cancer patients in a Chinese population.
    Zhu Y; Zhai K; Ke J; Li J; Gong Y; Yang Y; Tian J; Zhang Y; Zou D; Peng X; Gong J; Zhong R; Huang K; Chang J; Miao X
    Oncotarget; 2017 May; 8(22):36033-36039. PubMed ID: 28415599
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. A retrospective cohort study of pancreatic neuroendocrine tumors at single institution over 15 years: New proposal for low- and high-grade groups, validation of a nomogram for prognosis, and novel follow-up strategy for liver metastases.
    Ye L; Ye H; Zhou Q; Li Z; Lin Q; Tan L; Gao W; Fu Z; Zheng S; Chen R
    Int J Surg; 2016 May; 29():108-17. PubMed ID: 27000717
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Multimodal cancer care in poor prognosis cancers: Resection drives long-term outcomes.
    Healy MA; Yin H; Wong SL
    J Surg Oncol; 2016 May; 113(6):599-604. PubMed ID: 26953166
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Significance and prognostic value of increased serum direct bilirubin level for lymph node metastasis in Chinese rectal cancer patients.
    Gao C; Fang L; Li JT; Zhao HC
    World J Gastroenterol; 2016 Feb; 22(8):2576-84. PubMed ID: 26937145
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. pancreatic primary lymphoma: a case report and review of the literature.
    Ji Y; Kuang TT; Tan YS; Chen Y; Zeng HY; Jin DY
    Hepatobiliary Pancreat Dis Int; 2005 Nov; 4(4):622-6. PubMed ID: 16286277
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.